DE10162745A1 - Heterocyclylaminocarbonyluracile - Google Patents

Heterocyclylaminocarbonyluracile

Info

Publication number
DE10162745A1
DE10162745A1 DE10162745A DE10162745A DE10162745A1 DE 10162745 A1 DE10162745 A1 DE 10162745A1 DE 10162745 A DE10162745 A DE 10162745A DE 10162745 A DE10162745 A DE 10162745A DE 10162745 A1 DE10162745 A1 DE 10162745A1
Authority
DE
Germany
Prior art keywords
compounds
alkyl
halogen
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10162745A
Other languages
German (de)
English (en)
Inventor
Niels Svenstrup
Thomas Lampe
Dietmar Flubacher
Alexander Kuhl
Kerstin Ehlert
Michael Brands
Michael Otteneder
Joerg Keldenich
Christoph Ladel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE10162745A priority Critical patent/DE10162745A1/de
Priority to PCT/EP2002/014625 priority patent/WO2003053959A1/fr
Priority to AU2002364293A priority patent/AU2002364293A1/en
Publication of DE10162745A1 publication Critical patent/DE10162745A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE10162745A 2001-12-20 2001-12-20 Heterocyclylaminocarbonyluracile Withdrawn DE10162745A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE10162745A DE10162745A1 (de) 2001-12-20 2001-12-20 Heterocyclylaminocarbonyluracile
PCT/EP2002/014625 WO2003053959A1 (fr) 2001-12-20 2002-12-20 Heterocyclylaminocarbo nyluraciles
AU2002364293A AU2002364293A1 (en) 2001-12-20 2002-12-20 Heterocyclylamino carbonyluracils

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10162745A DE10162745A1 (de) 2001-12-20 2001-12-20 Heterocyclylaminocarbonyluracile

Publications (1)

Publication Number Publication Date
DE10162745A1 true DE10162745A1 (de) 2003-07-03

Family

ID=7710029

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10162745A Withdrawn DE10162745A1 (de) 2001-12-20 2001-12-20 Heterocyclylaminocarbonyluracile

Country Status (3)

Country Link
AU (1) AU2002364293A1 (fr)
DE (1) DE10162745A1 (fr)
WO (1) WO2003053959A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417180B1 (en) * 1998-10-07 2002-07-09 University Of Massachusetts Zinc finger-reactive antimicrobial compounds
WO2003011297A1 (fr) * 2001-06-15 2003-02-13 University Of Massachusetts 6-anilinopyrimidines n3-substituees et methodes de traitement d'infections gram-positif bacteriennes et mycoplasmiques

Also Published As

Publication number Publication date
WO2003053959A8 (fr) 2005-03-17
AU2002364293A1 (en) 2003-07-09
WO2003053959A1 (fr) 2003-07-03

Similar Documents

Publication Publication Date Title
EP1853582B1 (fr) Imidazoles substitues par heterocyclylamide
DE10208256A1 (de) Piperidinouracile
WO2005028451A1 (fr) Tetrahydrochinoxalines et leur utilisation comme agonistes du recepteur a l'acetylcholine m2
EP1866291B1 (fr) Macrocycles d'amide antibacteriens vi
EP1809653B1 (fr) Nonadepsipeptides substitues
DE10358824A1 (de) Antibakterielle Makrozyklen mit substituiertem Biphenyl
EP1526896A1 (fr) Macrocycles d'ester antibacteriens
EP1594864A1 (fr) Benzofuranoxyethylamines servant d'antidepresseurs et d'anxiolytiques
DE10133277A1 (de) ß-Alanin-Derivate
EP1732901B1 (fr) Composes imidazole a substitution 4-aminocarbonylamino a activite antivirale
DE10061542A1 (de) Alkanoylamino-pyrimidine
DE10162745A1 (de) Heterocyclylaminocarbonyluracile
DE10061537A1 (de) beta-Alanin-Derivate
WO2003000665A1 (fr) Derives d'uracile antibacteriens
EP1529042B1 (fr) Arylamides
US20090149528A1 (en) Cinnamic acid amides
WO2003000664A1 (fr) Derives d'uracile et leur utilisation pour traiter des maladies bacteriennes
DE10208460A1 (de) Uracil-Thioether
WO2004072067A1 (fr) Derives de benzofurane et leur utilisation en tant qu'antidepresseurs et anxiolytiques
DE10243201A1 (de) Alkyl- und Alkenylamide
DE10242488A1 (de) Dibenzoxazeptine
DE10064778A1 (de) Cyclisch substituierte Phenylamino-uracile
DE102005021963A1 (de) Substituierte Dihydropyrazolotriazinone
DE102004018405A1 (de) Antibakterielle Amid-Makrozyklen II
DE10219225A1 (de) Serinderivate

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: BAYER HEALTHCARE AG, 51373 LEVERKUSEN, DE

8130 Withdrawal